These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38162661)

  • 1. Exploring the gut mycobiome: differential composition and clinical associations in hypertension, chronic kidney disease, and their comorbidity.
    Qiu J; Zhao L; Cheng Y; Chen Q; Xu Y; Lu Y; Gao J; Lei W; Yan C; Ling Z; Wu S
    Front Immunol; 2023; 14():1317809. PubMed ID: 38162661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains.
    Zou Y; Ge A; Lydia B; Huang C; Wang Q; Yu Y
    Front Immunol; 2022; 13():1089295. PubMed ID: 36643913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated With Immunological Profiles.
    Hu J; Wei S; Gu Y; Wang Y; Feng Y; Sheng J; Hu L; Gu C; Jiang P; Tian Y; Guo W; Lv L; Liu F; Zou Y; Yan F; Feng N
    Front Immunol; 2022; 13():843695. PubMed ID: 35784313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension.
    Chen BY; Lin WZ; Li YL; Bi C; Du LJ; Liu Y; Zhou LJ; Liu T; Xu S; Shi CJ; Zhu H; Wang YL; Sun JY; Liu Y; Zhang WC; Zhang Z; Zhang HL; Zhu YQ; Duan SZ
    Microbiol Spectr; 2023 Feb; 11(1):e0195622. PubMed ID: 36475759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    Yadav M; Ali S; Shrode RL; Shahi SK; Jensen SN; Hoang J; Cassidy S; Olalde H; Guseva N; Paullus M; Cherwin C; Wang K; Cho T; Kamholz J; Mangalam AK
    PLoS One; 2022; 17(4):e0264556. PubMed ID: 35472144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
    Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
    J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic foot exacerbates gut mycobiome dysbiosis in adult patients with type 2 diabetes mellitus: revealing diagnostic markers.
    Cai Y; Li Y; Xiong Y; Geng X; Kang Y; Yang Y
    Nutr Diabetes; 2024 Sep; 14(1):71. PubMed ID: 39223127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes.
    Ren Y; Chen L; Guo R; Ma S; Li S; Zhang Y; Jiang H; Shi H; Zhang P
    J Transl Med; 2024 Feb; 22(1):202. PubMed ID: 38403655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

  • 14. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
    Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
    J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Level Configurations of Gut Mycobiome Across 6 Ethnicities in Urban and Rural China.
    Sun Y; Zuo T; Cheung CP; Gu W; Wan Y; Zhang F; Chen N; Zhan H; Yeoh YK; Niu J; Du Y; Zhang F; Wen Y; Yu J; Sung JJY; Chan PKS; Chan FKL; Wang K; Ng SC; Miao Y
    Gastroenterology; 2021 Jan; 160(1):272-286.e11. PubMed ID: 32956679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.
    Yang X; Cai S; Gong J; Zhang J; Lian M; Chen R; Zhou L; Bai P; Liu B; Zhuang M; Tan H; Xu J; Li M
    Int Urol Nephrol; 2024 May; 56(5):1751-1762. PubMed ID: 38085410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Pietrzak B; Schmidt M; Galus Ł; Mackiewicz J; Mackiewicz A; Kozlowski P; Philips A
    Cancer Immunol Res; 2024 Apr; 12(4):427-439. PubMed ID: 38315788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut mycobiome alterations in obesity in geographically different regions.
    Zhan H; Wan Y; Sun Y; Xu Z; Zhang F; Yang K; Zhu W; Cheung CP; Tang W; Ng EK; Wong SK; Yeoh YK; Kl Chan F; Miao Y; Zuo T; Zeng Z; Ng SC
    Gut Microbes; 2024; 16(1):2367297. PubMed ID: 38899956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.